Select Language
COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global 3D Bioprinting Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 3D Bioprinters
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Syringe/Extrusion Bioprinting
6.1.2.2 Inkjet Bioprinting
6.1.2.3 Magnetic Levitation Bioprinting
6.1.2.4 Laser-assisted Bioprinting
6.1.2.5 Others
6.1.3 Market Forecast
6.2 Scaffolds
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Biomaterials
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Living Cells
6.3.2.2 Hydrogels
6.3.2.3 Extracellular Matrices
6.3.2.4 Others
6.3.3 Market Forecast
7 Market Breakup by Application
7.1 Research
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Drug Research
7.1.2.2 Regenerative Medicine
7.1.2.3 3D Cell Culture
7.1.3 Market Forecast
7.2 Clinical
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Skin
7.2.2.2 Bone and Cartilage
7.2.2.3 Blood Vessels
7.2.2.4 Others
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Organization and Academic Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Biopharmaceuticals Companies
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3D Systems Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Aspect Biosystems Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cellink
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Cyfuse Biomedical K.K.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Materialise
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Organovo Holdings Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Poietis
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 RegenHU
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Stratasys Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
List of Figures
Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2021
Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2021
Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2021
Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2021
Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2021
Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2022-2027
Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: 3D Bioprinting Market: Competitive Structure
Table 7: Global: 3D Bioprinting Market: Key Players
The global 3D bioprinting market was valued at US$ 869 Million in 2021.
We expect the global 3D bioprinting market to exhibit a CAGR of 16.85% during 2022-2027.
The increasing application of 3D bioprinting for liver modeling and development of medical implants, is
currently catalyzing the global 3D bioprinting market.
The sudden outbreak of the COVID-19 pandemic has led to the rising use for 3D bioprinting as a rapid
fabrication method for designing and producing preventive, diagnostic, and treatment devices to
combat the spread of coronavirus infection.
Based on the component, the global 3D bioprinting market can be segmented into 3D bioprinters,
scaffolds, and biomaterials. Among these, 3D bioprinters, including syringe/extrusion bioprinting
currently holds the majority of the total market share.
Based on the application, the global 3D bioprinting market has been divided into research and clinical.
Currently, research exhibits a clear dominance in the market.
Based on the end user, the global 3D bioprinting market can be categorized into hospitals, research
organization and academic institutes, and biopharmaceuticals companies. Among these,
biopharmaceuticals companies currently account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global 3D bioprinting market include 3D Systems Inc., Aspect
Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM –
Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and
Stratasys Ltd.
10% Free customization
Purchase Options
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at
sales@imarcgroup.com